Evidence map›Paper›PMID 38779736›Full record

ReviewCurrent drug delivery2025

Ufasomes as Topical/Transdermal Drug Delivery System: Structural Components, Preparation Techniques and Therapeutic Application.

Sumayah Al-Mahmood, Nawal Rajab Ayash

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current drug delivery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sumayah Al-MahmoodDepartment of Pharmaceutics, College of Pharmacy, University of Baghdad, Baghdad, Iraq.ORCID 0000-0002-5887-8890
Nawal Rajab AyashDepartment of Pharmaceutics, College of Pharmacy, University of Baghdad, Baghdad, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fatty acid vesicles, or ufasomes, are spherical structures that encapsulate and deliver bioactive molecules to the skin or other tissues. They are formed from both saturated and unsaturated fatty acids and offer advantages over liposomes, including greater stability and a wider range of pH compatibility. They are composed of two layers of fatty acid molecules with their hydrocarbon tails facing inwards and their carboxylic groups facing outwards. The space between the two layers is filled with surfactants. There are various methods for characterizing and evaluating the properties of vesicles and drug-loaded vesicles, such as differential scanning calorimetry (DSC), Electron microscopy, UV-visible spectrophotometry, Dialysis, Franz diffusion cell, and stability testing. Each method provides specific information about the vesicles, such as their size, zeta potential, morphology, drug content, entrapment efficiency, drug release, permeability, and stability. Ufasomes have potential applications in topical/transdermal drug delivery as food additives, cosmetics, vaccines, gene therapy vectors, and diagnostic tools. Their ability to encapsulate and deliver bioactive molecules makes them valuable in various fields, including drug delivery and biomedical research. In summary, fatty acid vesicles represent a versatile drug delivery system with potential applications in various fields.

Indexed as

Drug CarriersDrug Delivery SystemsFatty AcidsAdministration, CutaneousAnimalsHumansLiposomesSkinSkin AbsorptionDrug CarriersFatty AcidsLiposomescholesterol.Drug deliveryfatty acidsoleic acidtopicaltransdermalufasomesvesicles

Identifiers

PMID38779736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.